SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-15-001800
Filing Date
2015-07-15
Accepted
2015-07-15 15:40:20
Documents
10
Period of Report
2015-05-31

Document Format Files

Seq Description Document Type Size
1 10-Q s101448_10q.htm 10-Q 174826
2 EXHIBIT 31.1 s101448_ex31-1.htm EX-31.1 8325
3 EXHIBIT 31.2 s101448_ex31-2.htm EX-31.2 8409
4 EXHIBIT 32.1 s101448_ex32-1.htm EX-32.1 4923
  Complete submission text file 0001615774-15-001800.txt   1617162

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cnlm-20150531.xml EX-101.INS 164200
6 XBRL SCHEMA FILE cnlm-20150531.xsd EX-101.SCH 24826
7 XBRL CALCULATION FILE cnlm-20150531_cal.xml EX-101.CAL 24516
8 XBRL DEFINITION FILE cnlm-20150531_def.xml EX-101.DEF 85377
9 XBRL LABEL FILE cnlm-20150531_lab.xml EX-101.LAB 167947
10 XBRL PRESENTATION FILE cnlm-20150531_pre.xml EX-101.PRE 134617
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500
CB Pharma Acquisition Corp. (Filer) CIK: 0001619551 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-36757 | Film No.: 15989302
SIC: 6770 Blank Checks